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Abstract

Cardiac arrest, characterized by the loss of mechanical activity of the heart, is a
life-threatening medical condition that is almost always fatal if not treated immediately.
The protocols for cardiopulmonary resuscitation used by emergency medical personnel
during out-of-hospital cardiac arrests do not account for cardiac and thoracic anatomic
variation when positioning chest compressions. This study will examine whether
evaluating chest compression efficacy using transthoracic echocardiography in the
prehospital setting will increase the rates of survival to hospital admission in adults
suffering atraumatic out-of-hospital cardiac arrest. We will recruit paramedics from four
emergency medical services agencies to participate in a prospective crossover study and
be trained in basic echocardiography to be used in the field. The results of this study may
support imaging in out-of-hospital settings to promote more effective cardiopulmonary
resuscitation, increasing rates of survival for patients suffering cardiac arrest.
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Chapter 1: Introduction
1.1 Background
Cardiac arrest is a deadly condition defined as the loss of mechanical activity of the
heart confirmed by the absence of signs of circulation.1 Over 350,000 people are treated
annually for cardiac arrests that occur out-of-hospital.1 Unfortunately, survival rates for
out-of-hospital cardiac arrests (OHCA) are quite low; only about 7.6% of adults
sustaining cardiac arrest outside of a hospital survive to be discharged from the hospital.2
Survivability of an OHCA varies widely depending on several factors, including
bystander cardiopulmonary resuscitation (CPR), availability and early use of an
automated external defibrillator (AED), and type of electrical rhythm present during
cardiac arrest.2 The timely application of high-quality chest compressions as part of CPR
has been proven to increase the likelihood of survival. Rapid and effective CPR may be
one of the reasons that in-hospital cardiac arrest survival rates are as high as 50%, which
is considerably higher than that of OHCAs.3 Patients who suffer cardiac arrest outside of
the hospital have low odds of survival unless the cardiac arrest is witnessed, CPR is
initiated quickly and performed effectively, and emergency medical services (EMS) are
activated promptly to ensure early defibrillation and advanced cardiac life support
(ACLS). The survivability of OHCA remains quite low, even in best case scenarios. Due
to the relatively small window of time in which a patient suffering an OHCA can survive,
many of the interventions aimed at improving survival rates have been incorporated by
EMS employees, specifically emergency medical technicians (EMTs) and paramedics.
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One of the newest diagnostic tools to be introduced in the prehospital setting is
the portable ultrasound device. Lightweight and low-cost, these devices are easily
integrated into the prehospital assessment and even during resuscitation. Several studies
examining the feasibility of prehospital ultrasound use have proven that paramedics can
be trained in basic echocardiography in a short period of time and apply these skills to
obtain high-quality images in the prehospital environment.4-6 Several prospective
observational studies have also been performed to determine the effect of paramedicguided echocardiography during cardiac arrest.7,8 Unfortunately, there are currently no
published randomized controlled studies that examine the effect of prehospital
echocardiography on patient outcomes, such as survival, in atraumatic cardiac arrest.9
1.2 Statement of the Problem
OHCA survival rates in non-traumatic adult arrests are only approximately 7.6%
nationwide2. In New Haven, the most recent data on survival show that 9.2% of patients
suffering non-traumatic cardiac arrest survive to discharge, and 11.2% survive to hospital
admission.10 Cardiac arrest survival increases with timely and effective CPR. There are
currently no imaging modalities widely available to prehospital clinicians to determine
whether CPR is being performed effectively in cardiac arrest.
In a recent Yale hypothesis-generating series of five patient cases, it was found
that unique patient anatomy limited the effectiveness of resuscitation with either manual
or automatic chest compression devices that did not directly cause compression of the left
ventricle, though properly positioned according to standard protocol.11 Focused
transthoracic echocardiography in the emergency department using parasternal long axis
and subxiphoid views showed that positioning of chest compressions in the standard
2

location compressed structures that were sub-optimal, such as the aorta and right heart.11
Swine models have shown that optimal hemodynamic parameters are achieved when the
left ventricle of the heart is directly compressed during CPR, thus enhancing the
likelihood of return of spontaneous circulation (ROSC).12 In the five cases published by
Dr. Liu et al., repositioning of chest compressions directly over the left ventricle using
visual information gathered from the echocardiogram resulted in ROSC in four patients,
and determined an etiology for the abrupt cardiac arrest in the fifth patient.
Unfortunately, in all five cases spontaneous circulation either could not be maintained for
a sufficient period of time, or the patient suffered significant neurological compromise
due to prolonged inadequate efforts at resuscitation.11 Currently, there have not been any
randomized studies performed on the efficacy of CPR positioning using focused
transthoracic echocardiography, either in the hospital or in the prehospital setting. In
summary, standard CPR positioning does not take natural anatomical variation in patients
into account; without an imaging modality to ascertain whether the correct anatomy is
being compressed, these patients have a very small likelihood of survival.
1.3 Goals and Objectives
EMS personnel provide rapid care to patients suffering OHCA. The rapid initiation of
uninterrupted effective CPR has been proven to improve likelihood of patient survival in
OHCA. By teaching paramedics to perform a basic echocardiographic assessment using a
portable ultrasound device, they can quickly assess whether the left ventricle of the heart
is being compressed effectively by the person or device performing CPR without
interrupting compressions. Effective compression of the left ventricle increases the
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likelihood of return of spontaneous circulation and hemodynamic stability, thus
increasing the likelihood of survival to hospital admission.
1.4 Hypothesis
We hypothesize that paramedic-performed focused transthoracic echocardiography in
cardiac arrest to determine accuracy of chest compression placement during CPR will
result in higher rates of survival to hospital admission when compared to standard care as
per statewide EMS protocols.

1.5 Definitions
Prehospital - occurring before or during transportation to a hospital
Out-of-hospital cardiac arrest (OHCA) - the loss of functional cardiac mechanical
activity in association with an absence of systemic circulation, occurring outside of a
hospital setting.13
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Chapter 2: Review of the Literature
2.1 Introduction
A systematic literature search was performed using multiple databases, including
Ovid (Medline), EMBASE, Scopus, Cochrane Medical Library, and Pubmed. The
literature search was performed between December 2019 and January 2020 using the
following terminology. Key terms used to search databases with respect to cardiac arrest
included out-of-hospital cardiac arrest, OHCA, heart arrest, cardiac arrest,
cardiopulmonary resuscitation, and CPR. Terms regarding imaging included
ultrasonography, ultrasound, POCUS, FEEL, echocardiography, echocardiogram, echo,
and transthoracic echocardiography. Key terms regarding the setting of the intervention
included emergency medical services, EMS, paramedic, emergency medicine, emergency
medical technician, prehospital, pre-hospital, and out-of-hospital. Key terms used to
search for specific protocol parameters included crossover study design, cross-over, and
cross over. Furthermore, searches were performed for the specific outcome being studied,
including survival, survival to admission, and survival to hospital admission. The search
was limited to adult population (ages 18 and older), articles published within the last ten
years, and articles in English. Article abstracts were subsequently screened for relevance.
2.2 Overview of the Burden of Out-Of-Hospital Cardiac Arrest
OHCA is frequently encountered and treated by emergency medical personnel in
the United States. 2019 estimates from the American Heart Association state that the
annual incidence of EMS-assessed OHCA in adults in the United States is 356,461 (95%
CI = 350,349-362,252).1 National estimates of survival to hospital discharge in 2017
6

from the Cardiac Arrest Registry to Enhance Survival (CARES) database were a dismal
10.4% among adults.2 Conversely, the in-hospital cardiac arrest rate of survival to
discharge is 25.6% (based on data from 311 US hospitals)3. There are large regional
variations in OHCA survival to hospital discharge, ranging from 3.4% to 22.0% (median
odds ratio = 1.40, 95% CI = 1.32-1.46).4 Based on 2018 calculations from the CARES
database, the national rate of survival to hospital admission following OHCA was
28.2%.2 These data indicate that there is room for improvement in the treatment of
OHCA, and that perhaps it is possible to increase patient survival rates.
Survivors of cardiac arrest also suffer from many functional impairments that
ultimately reduce their quality of life.5,6 Among the sequelae reported one year post-event
by 141 patients in a cohort that survived cardiac arrest, 13% displayed severe cognitive
deficits, 15% reported anxiety and depression, 28% displayed symptoms of posttraumatic
stress disorder (PTSD), and 52% complained of severe fatigue.7 This study demonstrates
that survival of cardiac arrest is not without long-term consequences that affect quality of
life.
2.3 Overview of Ultrasonography in the Prehospital Setting
As point-of-care ultrasound (POCUS) becomes more ubiquitous in both the
emergency department and in prehospital settings, clinicians have found new ways to
incorporate these devices into patient assessments to change the course of treatment. The
utility of prehospital POCUS has been most critically evaluated in the diagnosis and
treatment of cardiac arrest, trauma, and dyspnea.8 The findings regarding POCUS use in
the setting of cardiac arrest will be discussed below in the next section. A recent
systematic review detailed the findings of several studies that found utility in POCUS for
7

trauma patients.8 A prospective trial by Press et al. found that the specificities for
helicopter-based emergency medical personnel to identify hemoperitoneum and
pneumothorax using POCUS examination were 94.1% (95% CI = 89.2%-97%) and
99.5% (95% CI = 98.2%-99.9%), respectively.9 Sensitivities, on the other hand, were just
46% (95% CI = 27.1%-94.1%) and 18.7% (95% CI 8.9%-33.9%), respectively.9 These
data suggest that the helicopter-based emergency medical personnel participating in this
study were very good at identifying disease-free anatomy, but were much less accurate at
identifying pathological states. Another study found that identification of pneumothorax
by non-physician air medical personnel using prehospital POCUS had an overall
accuracy of 91% (95% CI = 85-95%) when compared to chest computed tomography,
with a specificity of 96% (95% CI = 90-98%) and a sensitivity of 68% (95% CI = 4685%).10 Once again, these data suggest that while prehospital clinicians are able to
adequately view normal anatomy on ultrasound, they struggle with identifying pathology.
Further training may be required to focus on the presentation of pathology in future trials.
Furthermore, the prehospital clinicians who participated in the study were composed of
flight nurses and paramedics, with a mean of 10.6 years of experience in air medical
services.10 The level of experience may dictate the skill with which these clinicians are
able to use POCUS. Additionally, flight nurses have different educational backgrounds
and a slightly different scope of practice than paramedics, and thus different strengths and
weaknesses.
POCUS has also been used in the evaluation of dyspnea, especially in patients
with multiple comorbidities. In patients with dyspnea, POCUS can be used to distinguish
dyspnea caused by congestive heart failure (CHF) from dyspnea caused by chronic
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obstructive pulmonary disease (COPD).11 This study by Neesse et al. determined that
POCUS-elicited pleural effusion was demonstrated in 100% of patients with dyspnea
caused by CHF, whereas it was only seen on 20% (p<0.01) of ultrasound recordings
performed in patients having COPD exacerbations, thus allowing emergency medical
clinicians to correlate other clinical findings to narrow their differential diagnosis.11 In
the prehospital setting, there are limited modalities available to discern causes of
dyspnea. Tools that are frequently used in the hospital, such as arterial blood gases and
chest x-rays, are simply not available in prehospital medicine. With only a few tools
(such as physical exam, capnography, and pulse oximetry) at their disposal, paramedics
in prehospital settings cannot easily discern the etiology of dyspnea and may be inclined
to withhold or delay interventions such as fluid resuscitation, for fear of exacerbating the
symptoms. The use of POCUS in this setting may provide prehospital clinicians with the
opportunity to narrow a broad differential diagnosis and deliver appropriate interventions.
2.4 Use of Echocardiography in Cardiac Arrest
Portable ultrasound devices have become increasingly prevalent in the prehospital
setting due to their relatively low cost, durability, and portability.12 Additionally, portable
ultrasound devices are accurate. One study by Vourvouri et al. showed 100% (kappa =
0.969) agreement with standard echocardiographic findings using portable ultrasound
devices for effusion, and 93% (kappa = 0.871) agreement for left ventricle function and
wall motion abnormalities.13 These data suggest that the portable ultrasound device is an
effective substitute for traditional echocardiographic equipment when the latter is
unavailable. Another study by Rugolotto et al. found a sensitivity of 97% and a
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specificity of 99% for echocardiographic evaluation of moderate to severe anatomic
pathology using a portable ultrasound device.14
There have been several influential studies performed to investigate the effects of
using ultrasonography in cardiac arrest on various outcomes, such as effect on treatment
decision and correlation of cardiac movement with survival.15,16 Unfortunately, there
have been no randomized, controlled studies to date that compare survival in groups
receiving prehospital echocardiography for OHCA to controls. A selection of prospective
observational studies has formed the basis of our understanding of prehospital
echocardiography thus far. In a study of 42 patients, Aichinger et al. found that the use of
echocardiography in non-traumatic OHCA to view cardiac movement (versus cardiac
standstill) predicted survival with a 97.1% positive predictive value.17 This study found
that of the 32 patients who had complete cardiac standstill on the echocardiographic
assessment during resuscitation, only one (3.1%) survived to hospital admission, whereas
four out of the ten patients (40%) with cardiac movement on the assessment survived to
hospital admission (p=0.008).17 This suggests that echocardiography can be used to
evaluate cardiac motion to predict prognosis in cardiac arrest patients. Using this
information, clinicians can use echocardiography to confirm lack of cardiac motion in
cases where termination of resuscitative efforts may be questionable. Many emergency
physicians now use bedside echocardiography as a means to support the decision to
terminate resuscitation.18 An observational study by Breitkreutz et al. in the prehospital
setting used a similar type of echocardiographic assessment to view cardiac motion.19
The authors found that the FEEL (focused echocardiographic evaluation in life support)
assessment was useful in differentiating between true cardiac arrest and profoundly low
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cardiac output, a distinction that can significantly alter patient management.19 Although
ACLS protocols dictate that a clinician should seek to find a cause of etiology of cardiac
arrest, there are no specific guidelines that address how to do so.20 Breitkreutz et al. found
that echocardiographic findings from the FEEL assessment resulted in a warranted
change in patient management 89% of the time.19 Peri-resuscitative echocardiography in
the hands of prehospital clinicians can provide a tool to determine the etiology of a
cardiac arrest, when no clear etiology is found with traditionally available tools. The
FEEL assessment can reveal conditions such as tamponade, profound hypovolemia, and
myocardial insufficiency as causes for abrupt cardiac arrest.19 Breitkreutz et al. found that
introducing this peri-resuscitative echocardiographic assessment had potential to be
useful in the prehospital setting, but had thus far mainly been taught to physicians in
acute care specialties.19 Further implementation in the prehospital setting may be useful,
but remains unproven given that no randomized trials using ultrasound technology and its
effect on survival currently exist. The study by Breitkreutz et al. was not randomized and
was limited by the fact that it did not independently review all images gathered due to
technical limitations. Furthermore, the study was conducted in Germany and employed
emergency physicians to perform the peri-resuscitative echocardiographic assessment.
Due to the much smaller number of emergency physicians practicing prehospital
medicine in the United States (when compared to paramedics and EMTs), it is difficult to
generalize these results to an American paramedic-based prehospital medicine system.
Based on the findings of Breitkreutz et al., a similar study set in a Dutch
helicopter emergency medical service enrolling 56 patients recently found that a
prehospital echocardiographic assessment resulted in treatment changes in 88% of
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cardiac arrests.16 In 32 patients, the ultrasound findings supported the termination of
resuscitation.16 In 21 patients, the ultrasound findings supported the continuation of
resuscitation efforts.16 This study was also key in elucidating some of the limitations of
introducing a peri-resuscitative intervention in a high stress environment. It was found
that a high number of case report forms, designed to record information about time of
cardiac arrest, start of basic life support (BLS), initial observed heart rhythm, timing of
ROSC or termination of resuscitation, were not filled out by the emergency physicians
staffing the EMS service. The speculated reasons for this lack of data were
“nonadherence to the protocol, a lack of time due to subsequent missions, or plain
forgetfulness,” as well as “dismissal of the entire procedure due to poor image quality, or
the impression the scan contributed nothing to patient management,” thus introducing
selection bias.16 Unfortunately, this suggests that such limitations may occur in other
studies that take place in the prehospital setting treating cardiac arrest if proper adherence
protocols are not implemented.
Portable echocardiography may also be useful in dictating the direction of patient
management beyond just the continuation or termination of resuscitative efforts. In a
retrospective analysis of the REASON study, Gaspari et al. implemented a bedside
echocardiographic assessment in patients in PEA (pulseless electrical activity) arrest.
Their findings helped identify a subset of patients with organized cardiac activity who
responded well to continuous adrenergic agents, resulting in higher rates of survival to
hospital admission.21 Although this study was not randomized and included patients
suffering cardiac arrest in the emergency department, as well as out-of-hospital, it is one
of the few studies available that examines how using echocardiography during cardiac
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arrest to determine treatment plans based on cardiac activity affected survival to hospital
admission. Patients with organized cardiac activity (as seen on echocardiography) treated
with epinephrine had a survival to hospital admission rate of 37.7%, compared to 45.5%
for patients with organized rhythms treated with standard ACLS (p<0.005).21 Patients
with disorganized activity treated with standard ACLS interventions demonstrated a rate
of survival to hospital admission of 17.9%, compared to 0% for patients with
disorganized activity receiving epinephrine (p<0.005).21 Although this trial did not
directly study the relationship between peri-resuscitative echocardiography and survival
to hospital admission, it did use echocardiography as a tool to view cardiac activity, and
determined that this procedure may have beneficial effects on survival.
2.5 Feasibility of Implementing Paramedic-Guided Echocardiography in a
Prehospital Environment
Determining whether prehospital clinicians can successfully be taught to perform
the assessment must be carefully considered as one of the challenges associated with
implementing a new assessment in the prehospital setting. Several studies examining the
effectiveness of echocardiography in the prehospital setting employed emergency
physicians to perform the echocardiographic assessment.19,22 This has both advantages
and disadvantages. Most emergency physicians are already competent in emergency
ultrasound and echocardiography, and only need a minimal amount of supplemental
training to implement this intervention in the prehospital setting.23 For example,
emergency physicians employing point-of-care echocardiography in an ICU setting were
able to obtain adequate images in 100% of the 151 enrolled patients.24 In most European
countries, emergency physicians are employed to deliver the bulk of prehospital care
under the Franco-German model of EMS delivery.25 However, in the United States,
13

emergency physicians who practice prehospital care are relatively uncommon.25 Instead,
paramedics and EMTs make up the majority of clinicians who deliver prehospital care.
It would be very difficult to conduct an adequately powered study with a
sufficiently large sample size using only emergency physicians to perform prehospital
interventions. Fortunately, in acknowledgement of this limitation, several studies have
also examined the feasibility of educating paramedics to successfully perform
echocardiographic assessments. Chin et al. found that 75% of paramedics were able to
identify at least one ventricle on echocardiographic assessment after a short 2 hour
training course, but recommended further training.26 Heegaard et al. implemented a sixhour long training course for paramedics (including three hours of practical training and
additional one hour of refresher training) in Focused Assessment Sonography in Trauma
(FAST) and abdominal aortic exams.27 The authors found that paramedics were able to
obtain adequate images in 92% of patients receiving the FAST exam (which includes a
cardiac exam component), as verified by experienced sonographers.27 The PUCA
(Paramedic Ultrasound in Cardiac Arrest) study, published in 2017 by Reed et al., set out
not only to determine whether paramedics could be trained to perform and interpret
echocardiography while delivering life support, but whether they could perform the
echocardiographic assessment during a short pulse-check window, and whether this
intervention affected the quality of cardiac arrest care.28 The training period for
paramedics in this trial consisted of a two-hour lecture alongside four hours of practical
sessions and simulations. The study found that paramedics obtained an adequate view of
the heart 80% of the time on the first try and 100% of the time on the subsequent
attempt.28 These views were deemed excellent/good or satisfactory 68% of the time on
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the first try.28 However, a view was only obtained within the 10-second pulse check
timeframe approximately 44% of the time.28 The study also found that performing the
echocardiographic assessment prolonged hands-off time during CPR to 17 seconds,
which is unacceptable per ACLS guidelines.20 It was determined that while paramedics
could feasibly be taught to perform adequate echocardiographic assessments during life
support with satisfactory views, this intervention also delayed life-saving care in some
cases.28 Fortunately, it is less likely that this issue will arise in our proposed trial because
paramedics will be instructed to perform the echocardiographic assessment while CPR is
ongoing, thus removing the need to perform the assessment during the short pause in
compressions.
2.6 Review of Confounding Variables
There are many potential confounding factors to consider when studying the
effect of an intervention in cardiac arrest on survival. Due to the unpredictable and
demanding nature of delivering life support outside of a hospital with limited available
tools, many factors may affect patient outcomes, including survival. Certain aspects of
the EMS system itself create unexpected effects on patient outcomes. For example, many
ambulance services, including those that are to be included in this trial, have crews of two
individuals that respond to 9-1-1 calls. Due to the demanding nature of caring for a
patient in cardiac arrest, it is often the case that a second crew of two individuals will
respond to the same call to provide necessary assistance. However, this may not always
be possible depending on the call volume or staffing available at that point in time. In a
study where one paramedic is designated to obtain an echocardiographic assessment
during cardiac arrest, it may be possible that more crew members are required to deliver
15

adequate care to the patient. In this case, a crew of four members will almost inevitably
deliver better care than a crew of two, and this may affect the patient’s survival. A study
by Sondheim et al. investigated the optimal number of crew members needed to collect
sufficient data from a new smartphone application designed to assist EMS personnel in
recording the timing of interventions performed.29 Using simulations, it was found that as
crew sizes increased from three to four members, totals delays in care time decreased
from 13.43 to 2.13 seconds (p<0.001).29 Similarly, increasing group size correlated to an
increase in the number of interventions recorded in the application (p=0.009).29 The
greatest improvements were seen between groups of three to groups of four. It was
determined that the application should not be used in groups of less than four due to the
increased likelihood of insufficient entries recorded and delays in care time. The
application from this study demonstrates that introducing a novel intervention in a
prehospital setting may add to the demand that EMS clinicians experience when
delivering care in the field. As the number of crew members increases, tasks can be
delegated and shared to ensure that patient care is not compromised. In our study, it will
be necessary to ensure that all paramedics responding to cardiac arrest calls are able to
work with an appropriate number of team members to ensure proper patient care delivery.
The level of experience of the paramedic performing the intervention is another
variable that may have a confounding effect on both willingness and ability to use
transthoracic echocardiography, as well as survival outcomes. A study of ambulance
crews’ length of experience and its effect on patient survival by Soo et al. found that
patients’ chances of survival increased once EMTs had 4 or more years of experience
(odds ratio 2.71, 95% CI 1.17-6.32, p=0.02) when compared to EMTs with less than a
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year of experience.30 Additionally, patients’ chances of survival increased when
paramedics had just one or more years of experience (odds ratio 2.68, 95% CI 1.056.82, p=0.04) when compared to paramedics with less than a year of experience.30
However, a more thorough systematic review by Dyson et al. found that there was no
clear evidence that EMS practitioner career experience or exposure to OHCA was
associated with survival rates.31 This was due largely in part to the limitations of the
studies reviewed, which included a lack of controlling for confounding. Although data on
whether clinician experience affects survival outcomes is inconclusive, this is a
confounder that should be controlled for during the final data analysis portion of the
study.
Studies have also shown that rates of survival in cardiac arrest are statistically
different based on race and socioeconomic status. In a study of 4053 cardiac arrests in
New York City, it was found that age-adjusted survival to hospital admission was
significantly higher in Caucasians (11.3%) when compared to African-Americans (6.0%,
p<0.01). Similarly, Caucasians also had a higher survival to hospital admission rate
when compared to Hispanics (8.6%, p<0.01).32 OHCA also occurs much more frequently
in poorer populations; OHCA rates were found to be nearly double (incidence rate ratio
1.9, 95% CI = 1.8-2.0) in census tracts from the lowest socioeconomic quartile when
compared to the highest socioeconomic quartile.33 According to data from the CARES
database, men are more likely to suffer non-traumatic OHCAs, composing 62.1% of
OHCA patients treated by EMS in 2018.34 Conversely, women made up just 32.9% of
OHCA patients.
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Comorbidities are another factor that has strong influence over survival from
cardiac arrest. In particular, obesity is likely to be a confounding variable as it not only
has an effect on survival, but also presents a challenge for clinicians attempting to obtain
images on echocardiography due to body habitus. In a prospective cohort of 81,722
women, BMI of 21.0-24.9 was associated with a decreased risk of sudden cardiac death
(RR=0.27) when compared to individuals with a BMI >35 (RR=1 p<0.01).35 Another
comorbidity that is common in those suffering OHCA is atherosclerosis. In a large study
of 1,274 patients occurring over the course of 10 years, patients suffering OHCA were
subjected to imaging (CT scan or coronary angiography) in the hospital.36 It was found
that 61% of patients who had suffered OHCA had at least one significant coronary lesion
that was thought to have contributed to cardiac arrest.36
Despite the wide variety of confounding variables associated with studies set in a
prehospital setting, the influence of these variables will be minimal due to the crossover
design of this trial. Participants will be matched, thus minimizing the effect of
demographic and comorbid condition confounding. Many trials with a crossover design
have a carryover effect inherent to the design of the trial that may act as a confounding
variable. Fortunately, the intervention used in our trial will not have this effect because
echocardiography will not have any lasting effects on the individual. Therefore, it will
not be necessary to incorporate a wash-out period in the study design.
2.7 Review of Relevant Methodology
The following sections will include reviews of methodology used in other
prominent trials relevant to the intervention and outcomes of our proposed study.
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2.7.1 Selection of Intervention
As discussed in previous sections, the use of portable ultrasound devices in the
prehospital setting has been of great interest to many researchers. The advent of portable,
affordable, and durable imaging has created an opportunity to implement a new imaging
tool earlier in the patient care process, prior to initiation of care in the emergency
department. As previously discussed, portable ultrasound has been amply studied in the
applications of cardiac arrest, trauma, and dyspnea.8 One study in particular found a
relatively novel use for portable ultrasound that seemed potentially applicable to the
prehospital setting. In a study of five patient cases in 2019, Liu et al. used portable
ultrasound devices to perform a very simple echocardiographic assessment of the heart
while chest compressions were performed, to determine whether the left ventricle was
adequately compressed.37 This study had several limitations, not least of which was its
strictly observational nature and small sample size of five patients. No conclusions about
patient outcomes could realistically be drawn from this small cohort. However, this study
did introduce an echocardiographic assessment that could be performed in the periresuscitative state without the need for pausing chest compressions. A previous study by
Reed et al. implementing an echocardiographic assessment during cardiac arrest found
that the addition of this new intervention during the 10 second “pulse check” window
resulted in longer pauses in CPR, which was deemed unacceptable.28 However, the
assessment proposed by Liu et al. does not require a pause in compressions, mitigating
the risk of delay in patient care.37 Additionally, the assessment proposed by Liu et al. was
relatively simple; it involved the use of modified parasternal long axis, apical fourchamber, and subxiphoid views to view the heart while compressions were in progress.
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Given the feasibility of teaching prehospital clinicians to perform similar assessments, it
appeared likely that prehospital clinicians could also learn to obtain the described views
with CPR in progress.26-28
2.7.2 Review of Study Design, Primary Outcomes, and Secondary Outcomes
The choice to perform a prospective randomized crossover study stemmed from
the use of crossover designs in other studies employing emergency medical personnel in
OHCA. A 2015 study by Nichol et al. enrolled patients suffering OHCAs into a trial
studying the effect of continuous versus interrupted chest compressions on survival to
hospital discharge.38 This study was implemented within the network of clinical sites of
the Resuscitation Outcomes Consortium, which included 114 EMS agencies across North
America. This expansive study allowed for a very large sample size, and the crossover
design minimized the effect of confounding variables due to matching. Of note, the
authors stated that some between-group differences were found in the characteristics of
patients, but these differences were attenuated through post hoc adjustment. As is
proposed in our study, randomization occurred at the institutional level, with EMS
agencies being assigned to individual randomization clusters. The primary outcome in
this study was rate of survival to hospital discharge, with secondary outcomes including
rates of transport to hospital, ROSC at ED arrival, admission to hospital, survival to 24
hours, days of hospital-free survival, discharge home, and neurological function based on
modified Rankin scale.38 Many of the outcomes studied in this trial are also proposed in
our study due to similarities in the population (patients suffering OHCA).
Another strong study published by Hallstrom et al. examined the effect of manual
versus mechanical chest compressions on survival to four hours after the 9-1-1 call.39
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Although this older study was published in 2006, it remains one of the few randomized
controlled studies that examines the effect of a peri-resuscitative intervention on survival.
Much like the trial published by Nichol et al., this study employs EMS personnel to
implement an intervention in patients suffering OHCA and uses a cluster-randomized
crossover design. The authors cite the “cost and inconvenience” of moving and carrying
the mechanical chest compression device as one of the primary reasons for the crossover
design.39 Similar to our proposed study, the crossover design allows researchers to
purchase half the amount of equipment needed for the intervention, since groups in the
clusters will switch protocols every specified time period. Furthermore, the cluster
randomization technique ensures that equipment can be swapped every few weeks or
months, rather than at every 9-1-1 response. The primary outcome in the Hallstrom study
was rate of survival to four hours after the 9-1-1 call, with secondary outcomes including
rates of survival to hospital discharge and neurologic function using a cerebral
performance score.39 Because survival to hospital discharge tends to be so rare, the
primary end point we have proposed in our study is survival to hospital admission. This
outcome is quite similar to the primary outcome in the study by Hallstrom et al., because
most patients who survive an OHCA in the emergency department will likely be admitted
to the hospital within less than 24 hours.
Additional studies that propose implementing new interventions during OHCA
have used mannequins or simulations as a substitute for real patients.40-42 This has the
benefit of testing outcomes such as chest compression depth, ratio of adequate
compressions, hands-off time, and clinician fatigue in the EMS setting, without
endangering patients.40 Unfortunately, the use of mannequins in OHCA trials precludes
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the ability to measure vital outcomes such as survival and neurological status, and
reduces generalizability. In order to study the effect that transthoracic echocardiography
has on the survival of patients suffering OHCA, we have opted to enroll qualifying
patients in our study, rather than use mannequins.

2.7.3 Inclusion and Exclusion Criteria
The exclusion criteria in our trial aim to exclude primarily patients who are of a
vulnerable population, those who suffered traumatic arrests, or those who cannot or do
not wish to be resuscitated. The exclusion criteria implemented by Nichol et al. were
detailed by Brown et al. in a 2016 manuscript.38,43 The populations selected for exclusion
included:
“patients with an EMS witnessed arrest; a written advance directive to not
resuscitate; blunt, penetrating, or burn related injury; obvious cause of arrest is
asphyxia, respiratory (asthma), drowning, strangulation, hanging, foreign body
obstruction, or mechanical suffocation; uncontrolled bleeding or exsanguinations;
known prisoners; known pregnancy; non-ROC EMS agency/provider first to
initiate chest compressions or place pads; mechanical compression device used
before any manual CPR by ROC personnel; advanced airway prior to ROC
agency arrival; pre-existing tracheostomy; or a priori opted out from resuscitation
research.”38,43
These criteria closely match those proposed in our trial. Due to very low survival rates
(ranging 0-3.1%), patients with cardiac arrest of a traumatic etiology are usually either
excluded from OHCA trials, or studied separately.44 Children, pregnant women, and
prisoners are vulnerable populations that are also frequently excluded from such trials.
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Hallstrom et al. used similar exclusion criteria as those used in the study by Nichol et al.,
with the addition of excluding patients who had had recent surgery.39 Though the authors
do not specifically address why patients with recent surgery were excluded, presumably
this may be because patients with recent surgery may have characteristics that resemble
those of patients who suffer traumatic cardiac arrests.
2.7.4 Baseline Characteristics of Patients
Many factors may affect survival in patients who suffer OHCA. Besides those
demographic qualities that were discussed earlier in the review of confounding variables,
many aspects of a cardiac arrest can affect whether an individual survives. Nichol et al.
analyzed the following pretreatment characteristics in their study of the effect of
continuous versus interrupted chest compressions on survival to hospital discharge: age,
sex, obvious cause of arrest, arrest occurring in public location, witness status, bystanderinitiated CPR, time from dispatch to first arrival of EMS, advanced life support on scene,
and study site.38 In the post-treatment characteristics, the authors included time between
arrival of EMS and start of CPR, first rhythm (shockable vs. non-shockable), number of
shocks given, prehospital intubation, CPR <6 min or until ROSC, drugs administered
before arrival at hospital, and hospital procedures.38 Many of these characteristics also
encompassed sub-characteristics to further delineate what factors may have affected
survival.38 However, this study had a massive sample size (26,148), more than 10 times
the sample size of the study proposed here.
Hallstrom et al. similarly designed a randomized controlled study implementing
an intervention in the population of adult patients suffering OHCA and studying its effect
on survival. The baseline characteristics analyzed in this study were similar but were not
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separated by pre- and post-treatment characteristics.39 The baseline characteristics
included here were age, sex, body type (thin, normal, obese, morbidly obese), witness of
arrest, CPR performed by bystander, public location of arrest, rhythm (shockable vs. nonshockable), time from 9-1-1 call to unit arrival, time from 9-1-1 call to initial rhythm
assessment, time from 9-1-1 call to first shock, number of compressions, proportion of
first 5 minutes on ECG with compressions, advanced airway placed, IV line inserted,
epinephrine/vasopressin/bicarbonate administered, death on scene, transport to hospital,
and hypothermia therapy.39
Many of the baseline characteristics analyzed in our proposed study were drawn
from the two above studies. Although the authors of these studies proposed different
interventions than ours, they studied similar outcomes in a similar population with strong
randomized study designs with crossover. A prospective cohort study by Stiell et al.
examined the optimal chest compression depth by reviewing data from the ROC
PRIMED trial to correlate chest compression depth with survival.45 The baseline
characteristics were more limited than those analyzed by the Nichol and Hallstrom
studies, but incorporated age, sex, bystander witness, bystander CPR, time to scene, time
to first shock, rhythm type, and other EMS interventions. Based on data from these
studies, we were able to compile a number of baseline characteristics to be analyzed in
the final data analysis portion of our proposed study.
2.7.5 Randomization Techniques

Data from the Nichol et al. trial and the Hallstrom et al. trial once again guided
the selection of randomization technique in our proposed study, due to the use of the
randomized crossover design in both trials. Nichol et al. enrolled 114 participating EMS
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agencies, which were grouped into 47 clusters.38 The clusters of agencies were
subsequently randomly assigned to perform continuous chest compressions or interrupted
chest compressions in a 1:1 ratio. Every six months, each cluster was crossed over to the
other resuscitation strategy. Though our proposed study will enroll only four EMS
agencies, these too will be clustered to include two in each cluster, which will then be
randomized to intervention or control in a 1:1 ratio. Cluster randomization was also used
by Hallstrom et al., with EMS agencies assigned to clusters within their site, and
subsequently randomized to either control (manual CPR) or intervention (mechanical
chest compression device) in a 1:1 ratio.39 Crossover occurred at specified time intervals
ranging from four weeks to two months. This randomization technique offers both
convenience and effectiveness of intervention implementation in the setting of
prehospital care. Hallstrom et al. specifically noted that the crossover design with cluster
randomization allowed for convenience of device transfer.39 In our proposed trial, this
randomization technique combined with the study design allows for the purchase of
fewer devices, and less time spent transferring devices between individuals. Perhaps even
more importantly, cluster randomization at the institutional level diminishes the time
spent making study-related decisions at the scene of a cardiac arrest, where time is crucial
to the delivery of life-saving care.
2.7.6 Sample Size
As previously noted, there have been no randomized controlled studies examining
the effect of prehospital echocardiography on survival in OHCA. However, there have
been a few randomized controlled studies that have examined the effect of other
prehospital interventions on the survival of patients suffering OHCA. These studies vary
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widely in terms of sample size. Nichol et al. enrolled a large sample size of 26,148
participants in their trial, which spanned 114 EMS agencies. Hallstrom et al. enrolled a
much smaller number of patients, totaling 1,071 participants. Both studies were able to
achieve statistical significance in either primary or secondary outcomes with their
respective approaches.
2.7.7 Informed Consent in Emergency Research
Obtaining consent for research in the prehospital setting can be quite challenging.
Prehospital emergencies often occur in austere environments and require time-sensitive
interventions. These challenges are further compounded when patients are unconscious,
as is the case with OHCA patients. To address challenges in obtaining informed consent
from patients in such dire circumstances, the Food and Drug Administration created a
protocol named the Exception From Informed Consent (EFIC) in 1996.46 This policy
exists to protect the rights of vulnerable patients while still promoting progress in medical
research. According to the most recently updated guidelines, EFIC in emergency research
situations “may only be conducted in unexpected, life-threatening circumstances where
(1) the patient is incapacitated, (2) available treatments are unproven or unsatisfactory,
(3) the proposed intervention may benefit the patient directly, and (4) the therapy must be
initiated before consent from the [legally authorized representative] is feasible.”47 This
allows the trial to proceed without requiring researchers to immediately obtain consent;
instead, informed consent is obtained when the patient is no longer incapacitated, or a
legally authorized representative, such as a spouse or family member, is available to
provide informed consent for the patient. Furthermore, a “community consultation” is
implemented to ensure that members of the community can reflect on the details of the
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study and raise potential concerns. In a 2014 study investigating the implementation of
community consultations across a variety of communities, it was found that the most
prevalent consultation method was attendance at meetings of existing community
groups.48 Knowledge of study content was high in these groups; increased study
knowledge correlated with increased interactivity of the consultation.48 The FDA
furthermore requires that following the completion of the proposed trial, public disclosure
is initiated to inform the community of the results of the study. Therefore, in order to
protect the rights of patients, we will use the FDA-approved EFIC guidelines. The
informed consent form can be found in Appendix 3.
2.8 Conclusion
Current evidence in emergency research suggests that, despite the advancement of
resuscitation techniques, survival rates in OHCA remain low. Portable ultrasound devices
have emerged as a novel tool that may be used in the prehospital setting to visualize
pathology contributing to cardiac arrest and other morbidity. One potential application of
these devices is in the setting of cardiac imaging; several studies have found that
echocardiography during the peri-resuscitative period in prehospital cardiac arrest may
lead to changes in treatment. There is evidence to suggest that it is feasible to teach
paramedics, who make up the bulk of ALS clinicians in the prehospital setting in the
United States, to perform echocardiographic assessments, correctly analyze the images,
and apply this knowledge to patient care. Confounding variables may be plentiful in the
setting of OHCA and survival outcomes, but the crossover study design will likely
mitigate many of these effects. Evidence from previous studies supports the selection of
the primary and secondary outcomes, as well as inclusion and exclusion criteria proposed
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in this study. Cluster randomization has also been adopted from previous studies as a
potentially convenient way to randomize subjects in a crossover study design, without
delaying patient care. Finally, a great deal of care has been taken to determine the most
ethical way to obtain informed consent in the prehospital setting; this trial will use a
consent process consistent with the FDA-approved Exception From Informed Consent
protocol.
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Chapter 3: Study Methods
3.1 Study Design
We will perform a prospective randomized crossover study involving four
Connecticut-based ground ambulance services. The services in question are divisions of
American Medical Response, Inc employing both BLS and ALS clinicians in Hartford,
New Haven, Waterbury, and Bridgeport. The four divisions employ roughly 450 ALS
clinicians who can participate in the trial, approximately equally distributed between the
four sites. An initial two-month training period will be devoted to didactic and clinical
education designed to train paramedics to perform focused echocardiographic
assessments during CPR. The four divisions will then be randomized to initially either
perform standard resuscitation on enrolled subjects or perform resuscitation with the aid
of a portable ultrasound device to guide chest compression positioning, with two
divisions in each group. The two divisions initially selected to be in the intervention
group will receive an appropriate number of portable ultrasound devices to be distributed
to all ALS units for use during cardiac arrest responses. Every two months the divisions
will switch protocols, for a total of 20 months. Patients enrolled in the study will be
followed for a total of 30 days after enrollment. An additional 30-day period will be
devoted to data analysis. Figure 1 shows a depiction of the study design.
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Figure 1: Study design protocol
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3.2 Study Population and Sampling
The study population will include adults 18 and older suffering non-traumatic
OHCA. Patients will automatically be excluded in cases where cardiopulmonary
resuscitation is not indicated, such as those with appropriate ‘do not resuscitate’ (DNR)
or advance directive orders in place, or obvious signs of death (lividity, decapitation,
transection, rigor mortis). Patients will also be excluded if they are known to be part of a
vulnerable population; these include children (ages <18), pregnant women, and prisoners
or wards of state. Sampling of patients will occur in a consecutive sampling method;
patients will be enrolled when an ALS unit arrives on scene and determines that the
patient is in cardiac arrest, provided he or she does not meet the exclusion criteria to the
best of the responding paramedic’s knowledge.
3.3 Subject Protection and Confidentiality
Prior to the initiation of training, we will obtain institutional review board (IRB)
approval by submitting an application according to the standard set in section 100 PR.1Review by a Convened Institutional Review Board of Yale University. This application
will include details of the process used to obtain informed consent as per guidelines of
the Exception From Informed Consent emergency research protocol. The consent will
explain the purpose of our research, procedures involved, and the duration of the study. It
will also clearly delineate risks and discomforts of participation in the research protocol,
as well as potential benefits. Though it will not be possible to obtain informed consent at
the time of enrollment due to the nature of our research, informed consent will be
obtained from the patient or a legally authorized representative as soon as possible. All
data pertaining to patients will be deidentified wherever possible and stored in an
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encrypted and password-protected server. Patients who do not wish to continue
participating in the trial or have their data included in the study will have all data
associated with their name removed from the server. Encryption of data, including
protected health information, will be completed in accordance with the Health Insurance
Portability and Accountability Act (HIPAA).
As part of the EFIC guidelines for obtaining consent, we will also perform
community consultations prior to the start of the trial but after IRB approval. The FDA
requires community consultations to occur as a means of disseminating information about
the study, including its risks and benefits. Prior to the start of the trial, we will take out
several ads in local city newspapers (the Hartford Courant, the Waterbury Observer, the
Connecticut Post, and the New Haven Register) detailing the goals, risks and benefits of
participation in the trial, as well as details about where community consultations will
occur and how enrollment will take place. After the study is complete, we will once again
take out ads in these local newspapers reporting the findings of the study and thanking
the community for its support and participation, as part of our public disclosure efforts.
As previously discussed, acceptance of EFIC protocol and recall of relevant study
details was highest when community consultations were held in existing community
groups and had interactive measures.1 In order to provide the local community with an
understanding of our proposed study and the enrollment process, we will plan a minimum
of four community consultation gatherings during this time period. One community
consultation will be performed in each of the communities that the four EMS agencies
serve: Hartford, Waterbury, New Haven, and Bridgeport. Since the best results are
produced when community consultations are held in existing community groups, the
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scheduling of the consultations will depend on existing community gatherings at that
time. The types of gatherings community consultations will occur in may include town
hall forums, church groups, and club meetings. Community consultations will be
advertised in advance. We will strive to ensure that attendance at the consultations is
relatively equal across the four communities and will schedule additional consultations if
necessary. During community consultations, we will explain pertinent study details,
including risks and benefits of participation, as well as a description of the EFIC
guidelines in layperson terms. At the conclusion of the meeting, surveys will be
distributed to all participants to measure study detail recall and levels of agreement with
EFIC enrollment. This process of community consultation will allow the members of the
communities to develop basic knowledge of the trial and express any concerns that may
need to be addressed prior to the start of the trial. Additionally, public disclosure of the
findings of the study will provide the community with an understanding of the impact of
the trial following its completion.
3.4 Recruitment
Whenever possible, an ALS unit staffed with an echocardiographic assessmenttrained paramedic is sent to any cardiac arrest call that occurs within the jurisdictions of
the four EMS services. In cases where an alternative dispatch turns out to be a patient in
cardiac arrest, an eligible ALS unit responds as soon as possible. Local first responders
(such as the police or fire departments) also respond. Patients will be enrolled in the trial
when an ALS unit arrives on scene of the call and the paramedic determines that the
patient is in cardiac arrest and does not meet any exclusion criteria. Since randomization
will be occurring at the institutional level, there will be no delay in delivering life-saving
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treatment to the patient. Unfortunately, in cases of OHCA, patient demographics and
causes of arrest are often unclear due to lack of bystander information and the patient’s
inability to advocate for themselves. In cases where it is not clear whether the patient is in
cardiac arrest due to a traumatic cause, the patient will be enrolled, but then later
excluded in the final data analysis if he or she is found to have entered cardiac arrest
because of trauma. Similarly, in cases where the patient does not appear to be a child,
pregnant, or a prisoner, and there is no bystander information available to suggest
otherwise, the patient will be assumed to not be a part of these vulnerable populations.
3.5 Study Variables and Measures
The intervention will be paramedic-performed focused transthoracic
echocardiography using a portable ultrasound device performed during CPR. The control
patients will receive standard CPR according to statewide EMS protocols without
paramedic-performed focused transthoracic echocardiography.2 The primary dependent
variable will be the proportion of patients surviving to hospital admission. Secondary
variables will include the proportion of patients in whom chest compression position is
adjusted, proportion of patients achieving ROSC, proportion of patients surviving to
hospital discharge, and neurological function at discharge (scored on modified Rankin
scale).
3.6 Blinding of Intervention
Patients will not be blinded to the intervention being performed, though most will
be unresponsive for the duration of their resuscitation due to the nature of cardiac arrest.
Therefore, the lack of subject blinding should not influence the results. The operators of
the interventions (EMS personnel) also cannot be blinded to the intervention. Hospital
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personnel cannot be reliably blinded to the intervention either, since the results of the
echocardiography in the intervention group may lead to important changes in treatment of
the patient that may be vital in the EMS report given to triage personnel.
3.7 Blinding of Outcome
This will be a single-blinded study. The assessor of the outcome will be blinded to
whether each subject was in the control group or the intervention group. He or she will be
asked to assess the subject’s medical record for survival data and neurological status,
without any knowledge of whether the subject received the intervention.
3.8 Assignment of Intervention
The initial randomization of the intervention among the four EMS services will be
performed by a computer program. Once randomized, the two pairs of services will swap
intervention/control every 60 days for the duration of the study; hence, randomization
will only occur once.
3.9 Adherence
Since the implementation of the intervention depends largely on the paramedics
providing primary treatment during a cardiac arrest, there will be several initiatives in
place to encourage their adherence to the protocol. A small monetary reward in the form
of a $20 Starbucks gift card will be awarded to all eligible paramedics who enroll patients
and use the intervention in at least 75% of eligible cardiac arrest patients they respond to.
Furthermore, in cases where eligible patients are not enrolled by paramedics, it will be
mandated that a “Non-Enrolled Patient” form be completed and reviewed to examine the
reasons for not implementing the intervention (see Appendix 1). Paramedics will be
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required to sign the portable ultrasound devices out of the office with their charging
devices and return them at the end of their shift with details of any issues or damages that
may have occurred during the shift. Unfortunately, several prior studies have described
issues with paramedics adhering to study protocols in trials involving prehospital
interventions.3,4 We believe that establishing several safeguards in place to encourage use
of the portable ultrasound devices will limit bias and confounding, and help enroll the
necessary number of participants to meet the required sample size.
3.10 Monitoring of Adverse Events
Similar studies have monitored a variety of adverse events in patients suffering
OHCA.5,6 Using these studies as a frame of reference, we will review patient charts for
the following adverse events: death, re-arrest, pulmonary edema, seizure, chest fracture,
pneumothorax, hemothorax, cardiac tamponade, cerebral bleeding, aspiration, and
internal organ injury. These are adverse events that can occur as a result of the aggressive
resuscitation performed during CPR or ACLS. Paramedics will be asked to comment on
adverse events in the enrolled patient forms. Information about subsequent adverse events
will be obtained from the patient’s medical record. The intervention itself (applying the
ultrasound probe to the chest) does not have any known serious adverse effects.
3.11 Data Collection
Data will be collected continually throughout the course of the trial. After the
initial two-month training period is complete, the 20-month enrollment period will begin.
Paramedics will be expected (and incentivized as above) to enroll eligible patients into
the trial when they are dispatched to cardiac arrests. Paramedics in the intervention group
will perform patient care as specified in the state protocols, with the only exception being
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the use of the portable ultrasound device during chest compression intervals.2 Paramedics
who enroll a patient into the trial will be expected to fill out a “Cardiac Arrest Trial
Enrollment Form” detailing whether they were able to elicit an adequate view using the
portable ultrasound device, whether the left ventricle was being adequately perfused, and
whether the imaging resulted in a change in compression positioning or patient
management (Appendix 2). A short narrative will be written detailing any changes in
patient management. Paramedics who do not enroll an eligible patient will complete a
similar form explaining why they were unable to or did not wish to comply with the trial
guidelines. Paramedics will be required to fill out the necessary forms the same day of
their shift to maximize retention. We hope that these forms will shed light on the factors
that contribute to changes in patient management, as well as possible equipment and
compliance issues, without interfering with or delaying emergent patient care at the time
of cardiac arrest.
Additional data on survival and adverse events will be collected from EMS run
forms and hospital records. Data will be collected in the electronic medical records at
Yale New Haven Hospital, Saint Francis Hospital, Hartford Hospital, Hospital of Central
Connecticut, Saint Vincent’s Hospital, Bridgeport Hospital, Waterbury Hospital, and
Saint Mary’s Hospital. A 30-day follow-up period ensures that we are able to collect the
necessary data from patients who may be hospitalized for extended periods of time
following cardiac arrest. Any patient who subsequently refuses to participate in the trial
will have his or her records expunged from all data collected in this trial.
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3.12 Sample Size Calculation
We are planning a study in which subjects will be randomized to either the
intervention or control at the institutional level at an approximately equal ratio. The
calculation of sample size is based on comparison of rates of survival to hospital
admission in a population of patients suffering OHCA receiving standard care, and is
averaged from several studies including those by Aichinger et al7, Nichol et al6,
Hallstrom et al.8, and Aufderheide et al5. The average rate of survival to hospital
admission in the control groups of these studies is 24%. The study will be powered at
80%, with a type I error of 5%. Currently there are no randomized, controlled studies
available on the use of ultrasound in prehospital cardiac arrest and its effect on survival.9
We are aiming to observe a 5% increase in the proportion of patients surviving to hospital
admission in the intervention group; this effect size was used in a similar study by
Aufderheide et al.5 Therefore, the calculated sample size is 1,222 patients in each group,
for a total of 2,444 participants. See Appendix 6 for further sample size calculation
details.

3.13 Statistical Analysis
Descriptive statistics will include age, sex, BMI, comorbidities, presumed cause
of cardiac arrest, downtime (in minutes), location of arrest (whether public), bystander
witness of arrest, bystander CPR, initial rhythm present, length of resuscitation (in
minutes), time from 9-1-1 call to arrival of unit (in minutes), and time between arrival of
EMS and CPR initiation (in minutes). Analysis will be performed under the intention-totreat protocol. A significance level will be set as p≤0.05. Continuous variables will be
represented as parametric means with standard deviation and will include the following:
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age, BMI, downtime, length of resuscitation, time from 9-1-1 call to arrival of unit, and
time between arrival of EMS and CPR initiation. If any of the baseline characteristics are
found to be nonparametric, they will be represented as medians with interquartile ranges
instead. Sex, occurrence of arrest in public area, bystander witness of arrest, and
bystander CPR will be analyzed as proportions. Finally, comorbidities, presumed cause
of arrest, and initial rhythm present will be analyzed as relative frequencies. The primary
outcome, survival to hospital admission, will be analyzed as a proportion with
McNemar’s test due to the matching of crossover groups. Although the crossover study
design minimizes the likelihood of imbalance of confounding variables between groups,
multivariate analysis may need to be performed. In this case, a conditional logistic
regression model will be used. Secondary variables analyzed using McNemar’s test will
include proportion of patients in whom chest compression position is adjusted, proportion
of patients achieving ROSC, and proportion of patients surviving to hospital discharge.
Neurological function at discharge (scored on modified Rankin scale) will be analyzed as
a median using the Wilcoxon signed-rank test. With the exception of neurological
function, which will be analyzed using the ordinal logistic regression model, multivariate
analysis of all other secondary outcomes will be performed using the conditional logistic
regression model.
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Table 1: Descriptive characteristics of enrolled patients

3.14 Timeline and Resources
The study period will be 24 months, beginning in January 2021. Prior to this time,
we will request approval from the Human Investigation Committee, which will take
approximately 3 months. From January 1, 2021 – March 1, 2021, paramedics in the four
AMR agencies will be assigned to didactic echocardiography training. Previous studies
have shown that paramedics can successfully obtain good images of the heart following a
single day of training that incorporates both didactic and practical sessions.4,10 A two44

hour didactic lecture will be followed by a two-hour long period of practice on an
ultrasound simulator and practice on volunteers. The didactic session will focus on using
the parasternal long axis (PSLA) and subxiphoid views for identification of the following
components of echocardiography: movement (presence of), function (quality of), and
chambers (particularly the left ventricle).10 The simulation and practice session will be
necessary to ensure that paramedics become comfortable with the equipment and learn
how to use it to obtain the correct views. The goal of the training will be to obtain a
satisfactory view of the left ventricle from the two views while compressions are being
simulated in <30 seconds. Paramedics will complete a short quiz at the end of the fourhour classroom training to test their knowledge and new skills. Paramedics will be shown
ultrasound clips and asked to identify the left ventricle and its quality of function.
Paramedics will also briefly be tested on their ability to obtain PSLA and subxiphoid
views on a volunteer in under 30 seconds. Paramedics who score <70% on the
administered quiz will be required to attend refresher training prior to participating in the
trial.
Following the four hours of classroom training and quiz, each paramedic will also
complete a scheduled 12-hour training shift in his or her sponsor hospital’s emergency
department, to practice performing the echocardiographic assessment on living patients.
If a patient in cardiac arrest presents to the emergency department, the paramedic will
have the opportunity to perform the echocardiographic assessment on the patient in
cardiac arrest. Paramedics who are newly hired after the trial has started, or those who
require additional training, will have the opportunity to attend a four-hour “refresher”
training session held monthly at one of the central stations of the EMS agencies.
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From March 1, 2021 – November 1, 2021, patients will be enrolled into the study
by trained paramedics. This 20-month period ensures that there is ample time to enroll
enough patients to reach the desired sample size. A 30-day follow-up period will begin
once the enrollment period is over. We estimate that an additional 30-day period will be
required for data analysis. The equipment requirement for this study will be
approximately 60 portable ultrasound devices. This is estimated based on the
approximation of 30 ALS units available for coverage on a given day at each EMS
agency. Since only half of the agencies will have portable ultrasound devices at any given
time, we can purchase enough portable ultrasound devices to be used at two agencies 24
hours a day. We will use Butterfly IQ probes, which are relatively small and durable, and
thus likely to survive the harsher conditions in the field relative to hospitals. At
approximately $2000 a unit, we estimate that the total cost of the devices will be
approximately $120,000. Paramedics will use their own smartphones to connect to the
device and view images, whenever possible. We will approach the manufacturer
regarding providing portable ultrasound devices at a discounted rate due to the volume of
the order. The study will also require a minimum of one training instructor to deliver
didactic and hands-on training. We will also need to employ a project oversight manager
to collect data from the EMS agencies and ensure it is properly entered into the project
database according to HIPAA standards.
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Chapter 4: Conclusion
4.1 Advantages and Disadvantages
The trial we have proposed here has several advantages. The intervention we are
implementing makes use of technology that is both effective and relatively inexpensive.
The study we have proposed investigates the effect of portable ultrasound technology in
the prehospital setting on survival to hospital admission, which has not been studied in
this context. As such, the results gathered from this study may provide the first data
available on the effect of this type of technology on survival in the prehospital setting.
The primary and secondary outcomes will provide data on survival to both hospital
admission and discharge, as well as neurological function at discharge. These data may
provide some insight not only on the survivability of cardiac arrest, but long-term patient
health as well. The study design is a randomized prospective crossover trial, which has
several benefits. The crossover design allows for greater convenience and decreases
costs, because it allows researchers to purchase fewer pieces of equipment. Because each
participant is matched due to the inherent structure of the crossover design, confounding
is mitigated. Another benefit of the study we have proposed is that it incorporates
paramedics from American Medical Response, Inc, a corporation that already has several
structured EMS agencies across Connecticut, and a national commitment to advancing
EMS research. The four EMS agencies we will be using to enroll patients cover diverse
and widespread areas of Connecticut, encompassing urban, suburban, and rural
communities. This ensures that we will be able to enroll participants from different
backgrounds with a wide variety of baseline characteristics. This in turn will allow for
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greater generalizability of results. Furthermore, because the four agencies collectively
employ approximately 450 paramedics and staff approximately 120 on any given day, we
will easily be able to enroll an adequate number of participants in our study to meet the
required sample size and appropriately power the study. We have determined that it is
feasible to train paramedics to perform and analyze the assessment we have proposed, as
described in Chapter 2. The paramedics who participate in our study will undergo a
training period that is extensive enough to ensure that they have all the necessary skills to
perform the echocardiographic assessment, based on data from prior studies.1-3 The study
timeline, which incorporates a 20-month participant enrollment period, allows ample time
to meet the sample size. The 30-day follow-up period additionally ensures that patients
who survive to hospital admission and remain admitted can be followed for an additional
month to track secondary outcomes.
Although our proposed study has many advantages, there are also several
disadvantages associated with the nature of prehospital medicine. Unfortunately, it is
impossible to obtain traditional informed consent in a prehospital setting where patients
are unconscious. We will utilize the EFIC protocol to obtain informed consent from the
participant or a legally authorized representative as soon as possible, but this process is
not ideal.4 However, this currently remains the only viable way to perform research in
emergency medicine when participants are incapacitated. Another challenge to our
study’s validity that may arise is the possible lack of adherence to study protocols by
participating paramedics, which is an issue that has arisen in other studies using
paramedics in the prehospital setting.5 Ketelaars et al. found that due to many different
possible factors (including lack of time, forgetfulness, and perceived lack of “usefulness”
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of the images obtained), paramedics often omitted data or case report forms from the
trial, resulting in unwanted selection bias. These issues may certainly arise in our
proposed study, but we have taken several steps to preemptively prevent this. Paramedics
will be offered a small monetary incentive for enrolling patients and filling out the
associated form (see Appendix 2). Furthermore, paramedics will also be required to
submit paperwork when they fail to enroll patients (see Appendix 1) to determine where
and why the failure occurred.
4.2 Clinical and/or Public Health Significance
As previously described, there currently are no randomized controlled studies
available examining the effect of prehospital ultrasound use on survival. Our proposed
study will result in the first set of data that examines how the use of ultrasound in the
prehospital setting affects survival rates. Because portable ultrasound devices may seem
to be a large monetary investment to many small EMS agencies, ultrasound technology is
still not widely available in the prehospital setting. If found to be positive, the evidence
garnered in this study could help support the decision to purchase ultrasound devices or
apply for grants or funding from local organizations to do so. Additionally, the data from
this study could have implications for how CPR is currently standardized. Since body
habitus and anatomical variations are currently not accounted for when performing CPR,
the data from this trial may show whether this needs to change to involve an
individualized approach to resuscitation. CPR is one of the most important components
of early care of cardiac arrest, yet it relies on the assumption that every person’s body
will be identically receptive to compressions. With the findings from this trial, we may be
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able to provide evidence to support a new method of CPR delivery that accounts for
individual anatomy.
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Appendix 2: Enrolled Patient Form
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Appendix 3: EFIC Consent Form
COMPOUND AUTHORIZATION AND CONSENT FOR PARTICIPATION IN A
RESEARCH STUDY
YALE UNIVERSITY SCHOOL OF MEDICINE
YALE-NEW HAVEN HOSPITAL

Study Title: Effect of prehospital echocardiography in cardiac arrest to augment
positioning of chest compressions
Principal Investigator (the person who is responsible for this research): Alexandra
Zhakov
Phone Number: (860) 816-6356
Research Study Summary:
•
•
•

•
•

•

We are asking you to continue being a part of our research study.
The purpose of this research study is to determine whether the use of paramedicguided echocardiography during cardiopulmonary resuscitation in out-of-hospital
cardiac arrest results in higher rates of survival to hospital admission.
Study procedures will include: There are two groups in this project. You were
enrolled in one of the two groups based on which branch of emergency medical
services responded to your 9-1-1 call for help. One group received the intervention,
which is the use of echocardiography during cardiopulmonary resuscitation. The
other group is the control, which means that people in this group receive standard
cardiopulmonary resuscitation as dictated by Connecticut emergency medical services
protocols.
There are no risks to continuing your participation in this study.
Taking part in the continuation of this study is your choice. You can choose to take
part, or you can choose not to take part in this study. You can also change your mind
at any time. Whatever choice you make, you will not lose access to your medical
care or give up any legal rights or benefits.
If you are interested in learning more about the study, please continue reading, or
have someone read to you, the rest of this document. Take as much time as you need
before you make your decision. Ask the study staff questions about anything you do
not understand. Once you understand the study, we will ask you if you wish to
continue to participate; if so, you will have to sign this form.
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Why is this study being offered to me?
We are asking you to take part in a research study because you suffered an out-ofhospital cardiac arrest and were given life-supporting care by emergency medical
services personnel.

Who is paying for the study?
Yale School of Medicine Physician Associate Program

What is the study about?
The purpose of this study is to determine whether the use of transthoracic
echocardiography during cardiopulmonary resuscitation will lead to higher rates of
survival to hospital admission. Transthoracic echocardiography is performed using a
Butterfly IQ portable ultrasound device, which was FDA-approved in 2017 for many
clinical purposes, including cardiac imaging. We use the Butterfly IQ ultrasound probe to
image the heart while it is being compressed during cardiopulmonary resuscitation.

What are you asking me to do and how long will it take?
You are being asked to continue to participate in this study because you suffered a
medical cardiac arrest outside of a hospital, and a bystander or loved one called 9-1-1 to
activate emergency medical services for help. The dispatcher sent an ambulance with
personnel who had advanced life support credentials. These personnel, the paramedics,
were instructed on how to follow this study’s protocols without delay of emergency care.
The paramedic assessed you, and instructed others to begin life-saving care. At the same
time, he or she determined that you met other criteria (such as being an adult, not
pregnant, not having any “do not resuscitate” directives, and not having been involved in
a traumatic event causing the cardiac arrest). You met enrollment criteria, and the
paramedic determined that you could participate in the trial. However, he or she did not
randomize you to the intervention or control group at that time. Randomization had
already occurred at the institutional level, meaning the paramedic was told in advance
whether the patients he or she enrolls will be in the intervention group or control group.
Unfortunately, the paramedic was not able to obtain informed consent from you or a
legally authorized representative at that time, because you were unresponsive and
delaying care would have been unethical. In cases like these, researchers are able to
enroll you in an emergency research trial provided that you or a legally authorized
representative give informed consent to continue participating in the trial as soon as
possible.
If you were in the control group, you received standard care, including cardiopulmonary
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resuscitation, as per statewide emergency medical services protocols. This means that the
paramedic and the rest of the emergency team did everything in their power to resuscitate
you. If you were in the intervention group, the paramedic and the rest of the team
delivered the same exact care as directed by statewide protocols, with one small
exception. While a member of the team was performing chest compressions to re-perfuse
your heart, the paramedic used a small, portable ultrasound probe to visualize your heart
by placing it over your chest. The probe uses soundwave technology to show an image of
the heart to the paramedic in real time. The images received by the probe allowed the
paramedic to determine whether the heart was pumping effectively during CPR, or
whether a small adjustment in positioning of chest compressions needed to be made. If
so, the paramedic would have asked the teammate performing chest compressions to
adjust his or her form, without interrupting CPR. This should not have affected your care
in any detrimental way, because CPR was not paused. The rest of your care was also not
changed.
You were transported to the hospital, and there you were registered and your care
continued as usual. Since the study aims to determine whether there will be an increase in
survival to hospital admission, an outcome assessor will need to view your medical
record, but he or she will not know whether you were in the intervention or control group.
Your consent is needed to use the information we have already collected, and to have the
outcome assessor view your record.

What are the risks and discomforts of participating?
There are minimal side effects associated with transthoracic echocardiography. This
intervention is not invasive. It involves placing a probe on the skin over your heart and
taking an image. This already took place; no further interventions are involved.
Direct side effects:
The main side effects that other people have experienced so far with transthoracic
echocardiography is discomfort from the ultrasound probe. However, this already took
place.
Additional side effects:

Another risk may be the paramedics’ inexperience with a new tool. Paramedics have been
trained to use the ultrasound probe with the explicit request that no other aspects of
patient care change. However, there are other paramedics present on the team that
responded to your emergency, who have not been previously exposed to this device. We
cannot guarantee that there were no changes to the speed with which care is delivered by
these personnel, as they adjust to the implementation of a new device in the resuscitation
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algorithm. Every effort has been made to train the paramedics involved in this protocol to
limit the amount of time spent performing the intervention in order to limit distractions
and delays in care. If you have questions, you can talk to the project director about
whether this risk may have applied to you.
Reproductive risks:
We do not know if the intervention causes harm to a baby, so we do not want anyone
who might be pregnant to enter the project.

How will I know about new risks or important information about the study?
We will tell you if we learn any new information that could change your mind about
taking part in this study.

How can the study possibly benefit me?
This study may or may not help you, but we hope the information from this study will
help us develop better treatments for cardiac arrest. This intervention is unlikely to
worsen your condition. Cardiac arrest, especially when occurring outside of a hospital,
has a very low survival rate. Your chances of survival depend largely on how well your
heart is perfused after you suffer a cardiac arrest. This intervention will attempt to lessen
the amount of time that your heart, brain, and other vital organs are poorly perfused. If
successful, this intervention may increase the likelihood of survival from cardiac arrest.

How can the study possibly benefit other people?
The benefits to science and other people may include a better understanding of how CPR
can be tailored to each individual person’s anatomy.

Are there any costs to participation?
You will not have to pay for taking part in this study.

Will I be paid for participation?
You will not be paid for taking part in this study.
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How will you keep my data safe and private?
We will keep information we collect about you confidential. We will share it with others
if you agree to it or when we have to do it because U.S. or state law requires it. We will
keep all data related to your care password protected in a secure database.
When we publish the results of the research or talk about it in conferences, we will not
use your name or other identifying information, such as your address or date of birth. We
will also not share information about you with other researchers for future research.

What Information Will You Collect About Me in this Study?
The information we are asking to use and share is called “Protected Health Information.”
It is protected by a federal law called the Privacy Rule of the Health Insurance Portability
and Accountability Act (HIPAA). In general, we cannot use or share your health
information for research without your permission. If you want, we can give you more
information about the Privacy Rule. Also, if you have any questions about the Privacy
Rule and your rights, you can speak to Yale Privacy Officer at 203-432-5919.
The specific information about you and your health that we will collect, use, and share
includes:
• Research study records
• Medical and laboratory records of only those services provided in connection with
this Study.
• The entire research record and any medical records held by the fire department that
responded to your cardiac arrest (if any), American Medical Response, Inc.
(if they transported you to the hospital), and associated hospitals created
from: 1/1/2021 to: 1/1/2023
• Records about phone calls made as part of this research
• Records about your study visit
• Information obtained during this research regarding
▪ Records about your medical condition
▪ Records about the study device
How will you use and share my information?
We will use your information to conduct the study described in this consent form.
We may share your information with:
•
The U.S. Department of Health and Human Services (DHHS) agencies
•
Representatives from Yale University, the Yale Human Research Protection
Program and the Institutional Review Board (the committee that reviews, approves,
and monitors research on human participants), who are responsible for ensuring
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•

•
•
•
•

research compliance. These individuals are required to keep all information
confidential.
The U.S. Food and Drug Administration (FDA) This is done so that the FDA can
review information about the portable ultrasound device involved in this research.
The information may also be used to meet the reporting requirements of drug
regulatory agencies.
The study sponsor or manufacturer of study drug/device
Co-Investigators and other investigators
Study Coordinator and Members of the Research Team
Data and Safety Monitoring Boards and others authorized to monitor the conduct of
the Study

We will do our best to make sure your information stays private. But, if we share
information with people who do not have to follow the Privacy Rule, your information
will no longer be protected by the Privacy Rule. Let us know if you have questions about
this. However, to better protect your health information, agreements are in place with
these individuals and/or companies that require that they keep your information
confidential.
Why must I sign this document?
By signing this form, you will allow researchers to continue to use and disclose your
information described above for this research study. This is to ensure that the information
related to this research is available to all parties who may need it for research purposes.
You always have the right to review and copy your health information in your medical
record.
What if I change my mind?
The authorization to use and disclose your health information collected during your
participation in this study will never expire. However, you may withdraw or take away
your permission at any time. You may withdraw your permission by telling the study
staff or by writing to Alexandra Zhakov at the Yale University, New Haven, CT 06520.
If you withdraw your permission, you will not be able to stay in this study but the care
you get from your doctors outside this study will not change. No new health information
identifying you will be gathered after the date you withdraw. Information that has already
been collected may still be used and given to others until the end of the research study to
insure the integrity of the study and/or study oversight.

What if I want to refuse or end participation before the study is over?
Taking part in this study is your choice. You can choose to take part, or you can choose
not to take part in this study. You also can change your mind at any time. Whatever
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choice you make, you will not lose access to your medical care or give up any legal rights
or benefits.

We would still treat you with standard therapy or, at your request, refer you to a clinic or
doctor who can offer this treatment. Not participating or withdrawing later will not harm
your relationship with your own doctors or with this institution.

To withdraw from the study, you can call a member of the research team at any time and
tell them that you no longer want to take part.

The researchers may withdraw you from participating in the research if necessary. This
may occur if you are discovered to not meet enrollment criteria, such as if you are:
pregnant, under 18 years of age, a prisoner, or ward of state.
What will happen with my data if I stop participating?
If you decide to stop participating in the study, all data and images associated with your
name will be deleted from our database.

Who should I contact if I have questions?
Please feel free to ask about anything you don't understand.

If you have questions later or if you have a research-related problem, you can call the
Principal Investigator at (860) 816-6356).

If you have questions about your rights as a research participant, or you have complaints
about this research, you call the Yale Institutional Review Boards at (203) 785-4688 or
email hrpp@yale.edu.

Authorization and Permission

Your signature below indicates that you have read this consent document and that you
agree to be in this study.
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We will give you a copy of this form.

Participant Printed Name

Participant Signature

Date

Person Obtaining Consent
Printed Name

Person Obtaining Consent
Signature

Date

Legally Authorized Representative
Name

LAR Signature

Date

Complete if the participant is not fluent in English and an interpreter was used to
obtain consent. Participants who do not read or understand English must not sign this
full consent form, but instead sign the short form translated into their native
language. This form should be signed by the investigator and interpreter only. If the
interpreter is affiliated with the study team, the signature of an impartial witness is also
required.
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Print name of interpreter: ______________________________________
Signature of interpreter: ___________________________________
_________

Date:

An oral translation of this document was administered to the participant in
_____________ (state language) by an individual proficient in English and
____________ (state language).
Print name of impartial witness: __________________________________
Signature of impartial witness: ________________________________
Date: _________
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Appendix 4: Instrument Used to Visualize Cardiac Contractility

Image 1: The Butterfly IQ probe attaches to smartphones and will be used by the
paramedic to visualize the left ventricle during cardiac arrest. It contains a built-in battery
which can be wirelessly charged. The device can perform up to 2 hours of continuous
scanning on a full charge.1

Reference:
1. Canepa CA, Harris NS. Ultrasound in Austere Environments. High Alt. Med. Biol.
2019;20(2):103-111.
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Appendix 5: Modified PSLA and Subxiphoid Views Obtained During CPR
The following images (provided by Liu et al.) depict how a clinician obtains the PSLA
and subxiphoid views while chest compressions are in progress.2
Image 1: A clinician obtains a modified PSLA view while another administers manual
chest compressions.

Image 2: A clinician obtains a subxiphoid view while automated chest compressions are
in progress.

Reference:
1. Liu RB, Bogucki S, Marcolini EG, et al. Guiding Cardiopulmonary Resuscitation
with Focused Echocardiography: A Report of Five Cases. Prehosp Emerg Care.
2019:1-9.

64

Appendix 6: Sample Size Calculation
Sample size based on a proportion calculator with assumed normal distribution.
-

-

Alpha (a) = 0.05 (two-tailed)
Beta (b) = 0.20, corresponding to 80% power
Risk in control group = P0 = 0.24
Risk in intervention group = P1 = 0.29
Effect size = 5%

Calculators used: Power and Precision 4.0, cross-referenced with UCSF Sample Size
Calculator (https://www.sample-size.net/sample-size-proportions/)
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